Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a …

YC Hsu, CY Chen, IW Chang, CY Chang… - The Lancet Infectious …, 2021 - thelancet.com
Background Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and minimally
raised alanine aminotransferase (ALT) is controversial. We aimed to investigate the efficacy …
被引用次数：39 相关文章

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a …

YC Hsu, CY Chen, IW Chang, CY Chang, CY Wu… - 2021 - cabidigitallibrary.org
Background: Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and
minimally raised alanine aminotransferase (ALT) is controversial. We aimed to investigate …

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a …

YC Hsu, CY Chen, IW Chang, CY Chang, CY Wu… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and minimally
raised alanine aminotransferase (ALT) is controversial. We aimed to investigate the efficacy …

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a …

YC Hsu, CY Chen, IW Chang, CY Chang… - The Lancet …, 2021 - scholar.nycu.edu.tw
Background: Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and
minimally raised alanine aminotransferase (ALT) is controversial. We aimed to investigate …

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a …

YC Hsu, CY Chen, IW Chang, CY Chang… - The Lancet Infectious …, 2021 - hub.tmu.edu.tw
Background: Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and
minimally raised alanine aminotransferase (ALT) is controversial. We aimed to investigate …

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a …

YC Hsu, CY Chen, IW Chang, CY Chang… - The Lancet Infectious …, 2021 - thelancet.com
Background Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and minimally
raised alanine aminotransferase (ALT) is controversial. We aimed to investigate the efficacy …

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a …

YC Hsu, CY Chen, IW Chang, CY Chang… - LANCET INFECTIOUS …, 2021 - ir.csmu.edu.tw
Background Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and minimally
raised alanine aminotransferase (ALT) is controversial. We aimed to investigate the efficacy …

[引用][C] Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH …

YC Hsu, CY Chen, IW Chang, CY Chang… - … DISEASES 21 (6) …, 2021 - ir.sinica.edu.tw
Issue Date: 2021-06 Relation: LANCET INFECTIOUS DISEASES 21 (6), 823-833 URI:
http://ir. sinica. edu. tw/handle/201000000A/81471 ISSN: http://gateway. isiknowledge …

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a …

YC Hsu, CY Chen, IW Chang, CY Chang… - The Lancet Infectious …, 2021 - Elsevier
Background Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and minimally
raised alanine aminotransferase (ALT) is controversial. We aimed to investigate the efficacy …

Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a …

YC Hsu, CY Chen, IW Chang, CY Chang… - The Lancet. Infectious …, 2021 - europepmc.org
Background Antiviral therapy for patients with non-cirrhotic chronic hepatitis B and minimally
raised alanine aminotransferase (ALT) is controversial. We aimed to investigate the efficacy …